Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Jim J. Zhang, Ph.D.
More GEN Content From This Contributor
- Feature Articles: Chinese Outsourcing Nears Full Service
- Feature Articles: Innovative Drug R&D on the Rise in China
- Feature Articles: Chinese Biopharma Industry Gaining Clout
- Feature Articles: Omics-Related Research On Rise in China
- Columns: Outsourcing Trends in China
- Columns: China and India in Global Drug R&D Outsourcing